Tag: Nac-C Plus

Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants

The authors present strong evidence that mitochondrial complex I defects are the major source of oxidative stress in TM cells of patients with POAG. Antioxidants such as Vit E and NAC are likely candidates to reduce ROS production and as complementary agents in the treatment of glaucoma.

Oxidative stress in the human trabecular meshwork clinically correlated with primary open-angle glaucoma

Study evaluated intensity of oxidative molecular damage and its clinical correlation to intraocular pressure. It found that oxidative stress could induce human trabecular meshwork degeneration, favoring an increase in IOP, leading to Glaucoma…

Clinical impact of inflammation in dry eye disease

We now have a clearer understanding of the inflammatory processes involved in DED, and there is hope that the still emerging preclinical/clinical findings will be translated into new and highly effective therapies for patients in the near future.

Study finds that Dry Eye Disease (DED) progression may be delayed by breaking the chronic cycle of ocular surface inflammation

The purpose of this article is to review the evidence for the hypothesis that the core mechanism of Dry Eye Disease (DED) is inflammation, including evidence from recent basic, clinical and translational research involving human patients, animal models, and cell cultures.

Dry eye characterized to have clinically-evident inflammation

Dry Eye type II is has been defined to be characterized by clinically-evident inflammation, and clear evidence of epithelial alterations. Type III Dry Eye is a chronic form with accompanied by clinically-evident and chronic inflammation.

Independent Study finds specific Amino Acids and Anti-Oxidants provide targeted support for those who suffer from IOP and Glaucoma.

This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally noted is that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients.

Nac-C Plus™ enhances Can-C™ eye drops to support vision health & repair

Nac-C Plus™ is the only supplement on the market that still uses the original formula invented & tested by Dr Mark Babizhayev to provide optimal support for his Can-C™ eye drops.